UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000013817
Receipt number R000016126
Scientific Title Jikei-Evaluation of basal insulin analogue on (nocturnal) glycemic variability with continuous glucose monitoring -existing basal insulin analogue versus Tresiba ; insulin degludec - a new basal insulin analogue, in basal-bolus treatment in type 1 diabetes-
Date of disclosure of the study information 2014/04/26
Last modified on 2016/10/26 12:42:38

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Jikei-Evaluation of basal insulin analogue on (nocturnal) glycemic variability with continuous glucose monitoring
-existing basal insulin analogue versus Tresiba ; insulin degludec - a new basal insulin analogue, in basal-bolus treatment in type 1 diabetes-

Acronym

JET-1

Scientific Title

Jikei-Evaluation of basal insulin analogue on (nocturnal) glycemic variability with continuous glucose monitoring
-existing basal insulin analogue versus Tresiba ; insulin degludec - a new basal insulin analogue, in basal-bolus treatment in type 1 diabetes-

Scientific Title:Acronym

JET-1

Region

Japan


Condition

Condition

Type 1 diabetes

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We compare glucose control of Degludec to ohter long-acting basal insulin analogue in Japanese patient with type 1 diabetes

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Continuous glucose value of 24 hours by CGM

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

insulin degludec

Interventions/Control_2

long-acting insulin analogue other than insulin degludec

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Type 1 diabetes receiving Basal-bolus insulin therapy.

Key exclusion criteria

Type 2 diabetes.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Rimei NIshimura

Organization

The Jikei University School of Medicine

Division name

Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine

Zip code


Address

3-25-8 Nishishinbashi, Minato-ku, Tokyo,Japan

TEL

+81334331111

Email

rimei@jikei.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Rimei NIshimura

Organization

The Jikei University School of Medicine

Division name

Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine

Zip code


Address

3-25-8 Nishishinbashi, Minato-ku, Tokyo,Japan

TEL

+81334331111

Homepage URL


Email

rimei@jikei.ac.jp


Sponsor or person

Institute

The Jikei University School of Medicine Japan Diabetes Foundation

Institute

Department

Personal name



Funding Source

Organization

Japan Diabetes Foundation

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 04 Month 26 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

Comparison of glycemic variability in Japanese patients with type 1 diabetes receiving insulin degludec versus insulin glargine using continuous glucose monitoring: A randomized, cross-over, pilot study.

Onda Y, Nishimura R, Ando K, Takahashi H, Tsujino D, Utsunomiya K.

Diabetes Res Clin Pract. 2016 Oct;120:149-55. doi: 10.1016/j.diabres.2016.07.019.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 10 Month 12 Day

Date of IRB


Anticipated trial start date

2014 Year 04 Month 26 Day

Last follow-up date

2015 Year 06 Month 01 Day

Date of closure to data entry

2015 Year 07 Month 01 Day

Date trial data considered complete

2015 Year 07 Month 01 Day

Date analysis concluded

2015 Year 12 Month 31 Day


Other

Other related information



Management information

Registered date

2014 Year 04 Month 26 Day

Last modified on

2016 Year 10 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016126


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name